Results 101 to 110 of about 78,497,869 (306)
Molecular Oncology, EarlyView.RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
University Hospitals Staff Meeting Bulletin, February 1, 1934
, 1934 University of Minnesota. University of Minnesota Hospitals. (1934). University Hospitals Staff Meeting Bulletin, February 1, 1934.
University of Minnesota. University of Minnesota Hospitals
core
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
University Hospitals Staff Meeting Bulletin, October 3, 1935
, 1935 University of Minnesota. University of Minnesota Hospitals. (1935). University Hospitals Staff Meeting Bulletin, October 3, 1935.
University of Minnesota. University of Minnesota Hospitals
core
PLoS ONEBackgroundDespite structured postgraduate clinical training programs in Japan, a considerable number of medical graduates have recently preferred community hospitals to university hospitals for postgraduate clinical training.
Keiko Hamatsu +5 more
doaj +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
University Hospitals General Staff Meeting, April 30, 1931
, 1931 University of Minnesota. University of Minnesota Hospitals. (1931). University Hospitals General Staff Meeting, April 30, 1931.
University of Minnesota. University of Minnesota Hospitals
core
Molecular Oncology, EarlyView.Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
University Hospitals Staff Meeting Bulletin, October 5, 1933
, 1933 University of Minnesota. University of Minnesota Hospitals. (1933). University Hospitals Staff Meeting Bulletin, October 5, 1933.
University of Minnesota. University of Minnesota Hospitals
core